FDA Issues New Policy for Evaluating the Impact of Viral Mutations on Covid-19 Tests
The new guidances for medical product developers, specifically covering vaccines, diagnostics, and therapeutic products, address the emergence and potential future emergence of variants of SARS-CoV-2, the virus that causes covid-19.
Read More